2021
DOI: 10.1016/j.chest.2021.06.058
|View full text |Cite
|
Sign up to set email alerts
|

IL-33 Depletion in COVID-19 Lungs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
22
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 17 publications
(22 citation statements)
references
References 11 publications
0
22
0
Order By: Relevance
“…Upon SARS-CoV-2 infection, IL-17 levels, along with other Th17 related proinflammatory cytokines, such as IL-1, IL-6, IL-15, TNF, and IFN-γ, are increased, which has a positive correlation with disease severity ( 101 , 102 , 208 ). Previous reports indicating the elevation of IL-17 levels in patients with SARS-CoV or MERS ( 209 , 210 ) as well as elevated IL-17 levels in SARS-CoV-2-induced cytokine storm ( 33 ), ALI ( 102 ), ARDS ( 37 ), viral load have been reported ( 77 , 211 ). A Janus kinase 2 inhibitor, Fedratinib, has been used to decrease IL-17 expression by inhibiting Th17 cells in murine models ( 212 ).…”
Section: Cytokine Secretion Induced By Sars-cov-2 Infectionmentioning
confidence: 86%
See 2 more Smart Citations
“…Upon SARS-CoV-2 infection, IL-17 levels, along with other Th17 related proinflammatory cytokines, such as IL-1, IL-6, IL-15, TNF, and IFN-γ, are increased, which has a positive correlation with disease severity ( 101 , 102 , 208 ). Previous reports indicating the elevation of IL-17 levels in patients with SARS-CoV or MERS ( 209 , 210 ) as well as elevated IL-17 levels in SARS-CoV-2-induced cytokine storm ( 33 ), ALI ( 102 ), ARDS ( 37 ), viral load have been reported ( 77 , 211 ). A Janus kinase 2 inhibitor, Fedratinib, has been used to decrease IL-17 expression by inhibiting Th17 cells in murine models ( 212 ).…”
Section: Cytokine Secretion Induced By Sars-cov-2 Infectionmentioning
confidence: 86%
“…IL-33 is an alarming and crucial immune modulator released by endothelial and epithelial cells, activated fibroblasts, fibroblast-like cells, and myofibroblasts to maintain the tissue and immune homeostasis and inflammation through IL-33/ST2 signaling ( 211 , 213 ). IL-33 plays important roles during allergic, fibrotic, infectious, and chronic inflammatory diseases by activating the different immune subgroups, such as Th1, Th2, T Reg , CD8 + T cells, mast cells, group 2 innate lymphoid cells (ILC2s), granulocytes, macrophages, DCs, NK cells, iNKT cells, and B cells ( 209 , 210 , 213 , 214 ).…”
Section: Cytokine Secretion Induced By Sars-cov-2 Infectionmentioning
confidence: 99%
See 1 more Smart Citation
“…Lung tissues were stained and analyzed for CIT- and MAA-modified antigens that included vimentin. Vimentin is an extracellular matrix protein that is increased in inflammatory lung diseases such as RA-ILD [ 34 , 41 , 42 ] and can be targeted by post-translational protein modifications, as demonstrated by robust co-localization with MAA in RA-ILD lung tissues [ 41 ]. By confocal microscopy, CIT- and MAA-modified proteins as well as vimentin were significantly increased in WT-ODE and DR4-ODE as compared to respective saline controls (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Beyond these inflammatory mediators, our studies have demonstrated that lung IL-33 levels are increased following airborne biohazard exposures, particularly in DR4 mice. As an alarmin that forms in response to damage or stress signals, IL-33 is increased in several inflammatory and fibrotic lung diseases that include COPD, idiopathic pulmonary fibrosis (IPF), post-COVID lung fibrosis, and RA-ILD [ 34 , 42 ]. Given that clinical studies targeting the systemic IL-33 signaling pathway are currently underway in the treatment of COPD (clinicaltrials.gov; NCT04701983; NCT03615040), investigating the role of IL-33 in HLA-DRB1 + RA and lung diseases resulting from airborne exposures may be warranted.…”
Section: Discussionmentioning
confidence: 99%